Ann: Half year results presentation, page-44

Mate I use to think MDC was a great play, would have been in my top three for undervalued cannabis plays on the ASX, but the decision making over the last year leaves a lot to be desired, they did an unncecessary consolidation which basically killed any price action in the stock, MDC probably has the lowest amount of shares on issue in the whole ASX, not only that you have CEO who despite achieving sweet F all pays himself exhorbitant salaries and performance rights, along with a lot of director related payments to family members, et al, a few red flags. I think they have the potentnial to come good just like BOT has done over these last months, but no rush to get in at the moment. They will be listing on the nasdaq apparently, maybe close to when that happens after a capital raise would be a good time to have a crack.